Siu Chung-Wah, Yeung Chun-Yip, Lau Chu-Pak, Kung Annie W C, Tse Hung-Fat
Cardiology Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Heart. 2007 Apr;93(4):483-7. doi: 10.1136/hrt.2006.100628. Epub 2006 Sep 27.
There are limited systematic data on the incidence, clinical characteristics and outcomes of congestive heart failure (CHF) in patients with hyperthyroidism. The aim of this study was to investigate the incidence, clinical characteristics and outcome of CHF as the initial presentation in patients with primary hyperthyroidism.
The prevalence, clinical characteristics and outcome of CHF was studied in 591 consecutive patients (mean (SD) age 45 (1) years, 140 men) who presented with primary hyperthyroidism.
CHF was the presenting condition in 34 patients (5.8%) with hyperthyroidism. The presence of atrial fibrillation at presentation (OR 37.4, 95% CI 9.72 to 144.0, p<0.001) was an independent predictor for the occurrence of CHF. Of the 34 patients with CHF, 16 (47%) had systolic left ventricular dysfunction with left ventricular ejection fraction (LVEF)<50%. They were predominantly male (OR 26.6, 95% CI 2.6 to 272.5, p = 0.006) and had a lower serum thyroxine level (OR 0.93, 95% CI 0.87 to 0.99, p = 0.044) than patients with preserved left ventricular systolic function. In these patients, LVEF (55 (4)% vs 30 (2)%, p<0.001) and New York Heart Association functional class (1.2 (0.1) vs 2.5 (0.2), p<0.001) improved significantly 3 months after achieving euthyroid status. Systolic left ventricular dysfunction (mean (SD) LVEF 38 (4)%) persisted on long-term follow-up in five
no clinical parameter could be identified to predict the occurrence of this persistent cardiomyopathy (p>0.05).
CHF was the initial clinical presentation in approximately 6% of patients with hyperthyroidism, and half of them had left ventricular systolic dysfunction. Symptoms of CHF subsided and LVEF improved after treatment for hyperthyroidism. Nonetheless, one-third of these patients developed persistent dilated cardiomyopathy.
关于甲状腺功能亢进症患者充血性心力衰竭(CHF)的发病率、临床特征和预后的系统性数据有限。本研究的目的是调查原发性甲状腺功能亢进症患者以CHF作为初始表现的发病率、临床特征和预后。
对591例连续就诊的原发性甲状腺功能亢进症患者(平均(标准差)年龄45(1)岁,男性140例)的CHF患病率、临床特征和预后进行研究。
34例(5.8%)甲状腺功能亢进症患者以CHF为首发症状。就诊时存在心房颤动(比值比37.4,95%可信区间9.72至144.0,p<0.001)是CHF发生的独立预测因素。在34例CHF患者中,16例(47%)存在收缩期左心室功能障碍,左心室射血分数(LVEF)<50%。与左心室收缩功能保留的患者相比,他们以男性为主(比值比26.6,95%可信区间2.6至272.5,p = 0.006),血清甲状腺素水平较低(比值比0.93,95%可信区间0.87至0.99,p = 0.044)。在这些患者中,达到甲状腺功能正常状态3个月后,LVEF(55(4)%对30(2)%,p<0.001)和纽约心脏协会功能分级(1.2(0.1)对2.5(0.2),p<0.001)显著改善。5例患者在长期随访中持续存在收缩期左心室功能障碍(平均(标准差)LVEF 38(4)%):无法确定任何临床参数来预测这种持续性心肌病的发生(p>0.05)。
CHF是约6%的甲状腺功能亢进症患者的初始临床表现,其中一半患者存在左心室收缩功能障碍。甲状腺功能亢进症治疗后,CHF症状缓解,LVEF改善。尽管如此,这些患者中有三分之一发展为持续性扩张型心肌病。